fatty acid synthase inhibitor

Advertisement

cGxPJobs Banner

Sagimet Begins Phase 1 Trial of Denifanstat-Resmetirom Combo in MASH

SAN MATEO, Calif., Oct. 1, 2025 — Sagimet Biosciences announced that it has dosed the first participants in a...

By cGxPwire Editor
October 1, 2025

Read More

Advertisement

cGxPJobs

Directory